Vanguard Global Advisers
VMD icon

Vanguard Global Advisers’s Viemed Healthcare VMD Stock Holding History

Vanguard Global Advisers’s Portfolio VMD Stock Details VMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$134K Hold
11,769
– – ﹤0.01% 2664
2026
Q1 		$108K Buy
+11,769
New +$97.9K ﹤0.01% 2694

Other funds holding VMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Forager Capital Management Birmingham, Alabama $266M AUM 40% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3B AUM 119.43% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return

Vanguard Global Advisers's VMD Position: Q2 2026 in Review

Vanguard Global Advisers held its Viemed Healthcare (VMD) position steady in Q2 2026 at 11,769 shares worth $134K. The position accounts for ﹤0.01% of the portfolio, ranked #2664.

Vanguard Global Advisers first reported a position in VMD in Q1 2026 and has held it in 2 quarters since. 164 funds tracked by Wall St. Rank hold VMD as of Q2 2026.

  • Vanguard Global Advisers held 11,769 shares of Viemed Healthcare worth $134K as of Q2 2026.
  • Vanguard Global Advisers left its Viemed Healthcare share count unchanged in Q2 2026.
  • Viemed Healthcare made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q2 2026, its #2664 holding.
  • Vanguard Global Advisers first reported a position in Viemed Healthcare in Q1 2026 and has held it in 2 quarters since.
  • 164 funds tracked by Wall St. Rank held Viemed Healthcare as of Q2 2026.

Based on Vanguard Global Advisers's 13F filing for Q2 2026, filed 13 Aug 2026.